Cargando…
2392. Identifying Associations Between Clostridium difficile Infection Incidence and Cancer Patients Receiving Chemotherapy
BACKGROUND: Clostridium difficile infection (CDI) is a known major financial burden. In the cancer population, CDI, was identified to have a peak incidence of 17.2 per 1000 patients with increased morbidity, mortality and hospital length of stay. The need to further elucidate chemotherapy (CTX) with...
Autores principales: | Louie Mendiola, Vincent, Kesireddy, Meghana, Suthar, Krishna, Willis, Maurice |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809772/ http://dx.doi.org/10.1093/ofid/ofz360.2070 |
Ejemplares similares
-
Nivolumab-Induced, Late-Onset, Steroid-Sensitive, High-Grade Pneumonitis and Durable Tumor Suppression in Metastatic Renal Cell Carcinoma: A Case Report
por: Mendiola, Vincent Louie, et al.
Publicado: (2019) -
514. The Effect of Probiotics on the Incidence of Clostridium difficile
por: Saltzman, Temima, et al.
Publicado: (2018) -
2381. Epidemiology of Clostridium difficile Infection in Patients Receiving Interleukin-2 Therapy
por: Li, Aldon, et al.
Publicado: (2019) -
2392. Fosfomycin Utilization and Outcomes in a Large VA Medical Center Over a Decade
por: Kraitman, Natan, et al.
Publicado: (2018) -
Incidence of Pediatric Community Associated Clostridium Difficile Infection Following Common Antibotics
por: Katz, Margot Miranda, et al.
Publicado: (2017)